Moomoo AI 已提取核心訊息
Teladoc Health, Inc. officer Nanis Nikolaos P. is set to sell 2,866 shares of common stock on 03/04/2024, as per the latest filing. The shares, valued at an aggregate market value of $41,601.71, were acquired on 03/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a recent history of sales by Nikolaos over the past three months, where a total of 1,028 shares were sold for gross proceeds of $20,708.85.
Teladoc Health, Inc. officer Nanis Nikolaos P. is set to sell 2,866 shares of common stock on 03/04/2024, as per the latest filing. The shares, valued at an aggregate market value of $41,601.71, were acquired on 03/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a recent history of sales by Nikolaos over the past three months, where a total of 1,028 shares were sold for gross proceeds of $20,708.85.
根據最新文件，Teladoc Health, Inc.高管納尼斯·尼古拉斯·P. 定於2024年4月3日出售2866股普通股。這些股票的總市值爲41,601.71美元，作爲發行人補償的一部分，於2024年1月3日通過限制性股票歸屬收購。該交易遵循了尼古拉奧斯在過去三個月中的近期銷售記錄，共出售了1,028股股票，總收益爲20,708.85美元。
根據最新文件，Teladoc Health, Inc.高管納尼斯·尼古拉斯·P. 定於2024年4月3日出售2866股普通股。這些股票的總市值爲41,601.71美元，作爲發行人補償的一部分，於2024年1月3日通過限制性股票歸屬收購。該交易遵循了尼古拉奧斯在過去三個月中的近期銷售記錄，共出售了1,028股股票，總收益爲20,708.85美元。
有用
沒用